InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by FRENKEL JACOB A. Officer active across 1 company, notably Brainstorm Cell Therapeutics INC.. In total, 2 disclosures have been published. History available since 1 January 2025. The latest transaction was disclosed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations